GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 701 filers reported holding GLAXOSMITHKLINE PLC in Q3 2014. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $822,000 | +2.4% | 21,044 | -7.0% | 0.48% | +0.4% |
Q4 2017 | $803,000 | -25.3% | 22,626 | -14.5% | 0.48% | -21.9% |
Q3 2017 | $1,075,000 | +12.9% | 26,473 | +20.0% | 0.62% | +8.3% |
Q2 2017 | $952,000 | -76.8% | 22,068 | -77.4% | 0.57% | -76.7% |
Q1 2017 | $4,111,000 | -7.0% | 97,510 | -15.1% | 2.44% | -14.0% |
Q4 2016 | $4,422,000 | -16.9% | 114,816 | -6.9% | 2.84% | -19.7% |
Q3 2016 | $5,319,000 | -3.3% | 123,321 | -2.8% | 3.54% | -3.2% |
Q2 2016 | $5,499,000 | +20.5% | 126,884 | +12.8% | 3.66% | +14.0% |
Q1 2016 | $4,563,000 | +9.0% | 112,535 | +8.4% | 3.21% | +20.4% |
Q4 2015 | $4,188,000 | +17.9% | 103,782 | +12.3% | 2.67% | +14.2% |
Q3 2015 | $3,553,000 | -1.8% | 92,399 | +6.4% | 2.33% | +17.3% |
Q2 2015 | $3,619,000 | -10.3% | 86,880 | -0.6% | 1.99% | -8.4% |
Q1 2015 | $4,035,000 | -1.0% | 87,435 | -8.3% | 2.17% | -10.2% |
Q4 2014 | $4,074,000 | -1.5% | 95,314 | +5.9% | 2.42% | -2.7% |
Q3 2014 | $4,137,000 | – | 90,004 | – | 2.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SENZAR ASSET MANAGEMENT, LLC | 668,200 | $30,717,000 | 9.01% |
Camber Capital Management LP | 1,200,000 | $55,164,000 | 5.18% |
Camber Capital Management LP | 1,000,000 | $45,970,000 | 4.32% |
Gary Goldberg Planning Services Inc | 178,496 | $8,205,000 | 3.41% |
Hamlin Capital Management, LLC | 1,217,870 | $55,985,000 | 3.36% |
Winch Advisory Services, LLC | 109,101 | $5,015,000 | 3.22% |
NORTHROAD CAPITAL MANAGEMENT LLC | 151,701 | $6,974,000 | 2.69% |
Reynders McVeigh Capital Management, LLC | 296,118 | $13,613,000 | 2.59% |
SALEM CAPITAL MANAGEMENT INC | 120,520 | $5,540,000 | 2.58% |
Keystone Financial Planning, Inc. | 74,338 | $3,417,000 | 2.58% |